Works matching IS 07703198 AND DT 2017 AND VI 36 AND IP 4


Results: 33
    1
    2
    3
    4
    5

    Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.

    Published in:
    Clinical Rheumatology, 2017, v. 36, n. 4, p. 781, doi. 10.1007/s10067-016-3489-1
    By:
    • Ørnbjerg, L.;
    • Østergaard, M.;
    • Jensen, T.;
    • Hørslev-Petersen, K.;
    • Stengaard-Pedersen, K.;
    • Junker, P.;
    • Ellingsen, T.;
    • Ahlquist, P.;
    • Lindegaard, H.;
    • Linauskas, A.;
    • Schlemmer, A.;
    • Dam, M.;
    • Hansen, I.;
    • Lottenburger, T.;
    • Ammitzbøll, C.;
    • Jørgensen, A.;
    • Krintel, S.;
    • Raun, J.;
    • Hetland, M.;
    • Slot, Ole
    Publication type:
    Article
    6
    7
    8
    9

    Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the 'pan-European registry collaboration for abatacept (PANABA).

    Published in:
    Clinical Rheumatology, 2017, v. 36, n. 4, p. 773, doi. 10.1007/s10067-016-3505-5
    By:
    • Iannone, Florenzo;
    • Courvoisier, Delphine;
    • Gottenberg, Jacques;
    • Hernandez, Maria;
    • Lie, Elisabeth;
    • Canhão, Helena;
    • Pavelka, Karel;
    • Hetland, Merete;
    • Turesson, Carl;
    • Mariette, Xavier;
    • Choquette, Denis;
    • Finckh, Axel
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    30
    31
    32
    33